EP3265565
Aðferðir til meðferðar krabbameins með arfstakt tap á TP53
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
3.3.2016EP published:
12.8.2020EP application number:
16710890.1
EP translation filed:
2.11.2020Grant published:
15.12.2020EPO information:
European Patent Register
Max expiry date:
2.3.2036Expiry date:
2.3.2027Next due date:
31.3.2027
Title:
METHODS OF TREATING CANCER HARBORING HEMIZYGOUS LOSS OF TP53
Timeline
Today
3.3.2016EP application
12.8.2020EP Publication
2.11.2020Translation submitted
15.12.2020Registration published
2.3.2027Expires
Owner
Name:
Board of Regents, The University of Texas SystemAddress:
210 West 7th Street, Austin, TX 78701, US
Inventor
Name:
LU, XiongbinAddress:
Houston, TX 77030, US
Name:
LIU, YunhuaAddress:
Indianapolis, IN 46202, US
Agent
Name:
KIPA ABAddress:
Pósthólf 1065, Drottninggatan 11, SE
Priority
Number:
201562128480 PDate:
4.3.2015Country:
US
Classification
Categories:
C12N 15/113, A61K 31/7088, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 8.2.2021
Expires: 2.3.2022
Payer: Árnason Faktor ehf.
Number: 7
Paid: 24.2.2022
Expires: 2.3.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 8.2.2023
Expires: 2.3.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 12.2.2024
Expires: 2.3.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 23.1.2025
Expires: 2.3.2026
Payer: UAB METIDA
Number: 11
Paid: 15.12.2025
Expires: 2.3.2027
Payer: UAB METIDA